#38, Dr. Mary Rozenman & Dr. Chris Probert, insitro
insitro, a company re-imagining drug discovery and development by integrating machine learning and biology at scale
AWS Health Innovation Podcast · AWS Startups
January 9, 202330m 12s
Audio is streamed directly from the publisher (dqharvrj7jnul.cloudfront.net) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Joe Shonkwiler is joined by Dr. Mary Rozenman, Chief Financial Officer and Chief Business Officer at insitro, and Dr. Chris Probert, senior machine learning scientist at insitro. insitro is a company re-imagining drug discovery and development by integrating machine learning and biology at scale.
Dr. Rozenman and Dr. Probert discuss how insitro’s discovery process can start on either the clinical or cellular side, why scale is so important in every aspect of insitro’s model, and why diversity of experience and background can be a powerful tool in solving hard problems.
Learn more about insitro (https://insitro.com/) and how AWS enables healthcare & life sciences startups to grow and thrive (https://aws.amazon.com/startups/ and https://aws.amazon.com/health/).